Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tue, 06/5/12 - 09:39 am
Amylin
M&A
Sanofi
AstraZeneca
Merck
Bristol-Myers Squibb
AstraZeneca bids $4bn for diabetes specialist Amylin
Telegraph, UK
Sun, 06/3/12 - 01:45 pm
AstraZeneca
Amylin
M&A
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sun, 06/3/12 - 12:23 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thu, 05/31/12 - 06:11 pm
Sanofi
liver cancer
GSK
AstraZeneca
Bristol-Myers Squibb
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thu, 05/31/12 - 09:38 am
AstraZeneca
JNJ
Bristol-Myers Squibb
Eli Lilly
Pfizer
Sanofi
GSK
The Race For Amylin Kicks Into High-Gear
Seeking Alpha
Wed, 05/30/12 - 03:01 pm
Amylin
M&A
AstraZeneca
Bristol-Myers Squibb
Pfizer
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wed, 05/30/12 - 11:30 am
generics
Effient
Plavix
Brilinta
Eli Lilly
bloodthinners
AstraZeneca
Sanofi
Bristol-Myers Squibb
Who Should Buy Amylin?
Motley Fool
Tue, 05/29/12 - 04:44 pm
M&A
Amylin
Sanofi
Merck
Bristol-Myers Squibb
Takeda
AstraZeneca
GlaxoSmithKline and AstraZeneca Invest in Antibiotic Research
PharmaLive
Tue, 05/29/12 - 04:43 pm
antibiotic resistance
antibiotics
GSK
AstraZeneca
5 Reasons To Buy Navidea Biopharmaceuticals
Seeking Alpha
Mon, 05/21/12 - 04:37 pm
Navidea Biopharmaceuticals
AstraZeneca
AstraZeneca looks to revive experimental drugs
Financial Times, UK
Sun, 05/20/12 - 12:34 pm
AstraZeneca
R&D
AstraZeneca appeal against competition law breach and level of fine imposed on it (in Europe) should be rejected, legal advisor says
Out-Law
Sat, 05/19/12 - 12:19 pm
AstraZeneca
legal
Plavix’s Loss Means Little Gain by Competing Blood Thinners
Bloomberg
Thu, 05/17/12 - 10:26 am
Plavix
bloodthinners
patents
Sanofi
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Amylin Goes A Little Wizard Of Oz On Shareholders
Seeking Alpha
Wed, 05/16/12 - 10:58 am
Amylin
AstraZeneca
Bristol-Myers Squibb
Pfizer
Sanofi
Novo Nordisk
M&A
Amylin climbs after report says seven companies involved in sales process
Yahoo/Fly on the Wall
Tue, 05/15/12 - 11:57 am
Amylin
Pfizer
AstraZeneca
Sanofi
Merck
Takeda
Roche
Bristol-Myers Squibb
M&A
4 Big Pharma Stocks To Nab In A Pullback
Seeking Alpha
Mon, 05/14/12 - 10:37 am
Merck
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Why Johnson & Johnson Looks Better Than Its Competitors
Seeking Alpha
Mon, 05/14/12 - 10:19 am
JNJ
Human Genome Sciences
Pfizer
Sanofi
Edwards Lifesciences
GSK
AstraZeneca
Pfizer Set To Surge On 3 New Drug Candidates
Seeking Alpha
Fri, 05/11/12 - 12:22 pm
Pfizer
Abbott Laboratories
Amgen
AstraZeneca
Watson Pharmaceuticals
JNJ
Bristol-Myers Squibb
Merck: Will Singulair Expiration Sink Its Stock?
Seeking Alpha
Tue, 05/8/12 - 10:55 am
Merck
Singulair
Novo Nordisk
Eli Lilly
JNJ
AstraZeneca
GSK
Pfizer Should Rise On New Gaucher Drug, Due Out In 2013
Seeking Alpha
Tue, 05/8/12 - 10:53 am
Pfizer
Gaucher disease
GSK
AstraZeneca
Eli Lilly
Shire
Protalix BioTherapeutics
Elelyso
Pages
« first
‹ previous
…
118
119
120
121
122
123
124
125
126
…
next ›
last »